REQUIP 0.50 mg, film-coated tablet 21 tablets
Active ingredients: Ropinirole hydrochloride, Ropinirol
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet21 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- REQUIP 0,50 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polyéthylène PVDC aluminium papier avec fermeture de sécurité enfant de 21 comprimé(s)
- Marketing authorisation holder
- GLAXOSMITHKLINE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Jul 2009
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66695638CIP73880177CIP133400938801774Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE ROPINIROLEcomprimé | 0,57 mg · un comprimé | SA |
| ROPINIROLE BASEcomprimé | 0,5 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.